August’s top retina headlines

FDA actions and coverage from the American Society of Retina Specialists meeting were some of the most-read retina-related articles on Healio.com/OSN during August.
Here are the top five retina headlines from the month:

Continuous glucose monitor may help reduce incidence of diabetic eye disease
Studies have shown that a reduction in HbA1c has a concomitant reduction in diabetic retinopathy. Read more.

FDA approves Eylea 12-week dosing for wet AMD
The FDA has approved a supplemental biologics license application for a 12-week dosing schedule of Eylea injection in wet age-related macular

Full Story →